⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1061800 | 1.00 | — | — | |
| SCHEMBL1352831 | 1.00 | — | — | |
| SCHEMBL730797 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL5666325 | 0.98 | CYP2D6 (0.56) | — | |
| Hydrochloric Acid SCHEMBL5698094 | 0.98 | CYP2D6 (0.56) | — | |
| Proline SCHEMBL10682077 | 0.85 | CYP1A2 (0.44) | — | |
| SCHEMBL13679506 | 0.79 | — | — | |
| SCHEMBL27280834 | 0.79 | — | — | |
| SCHEMBL242266 | 0.76 | — | — | |
| SCHEMBL5388393 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117757578-B | Semiconductor chip cleaning solution containing amino acid, preparation method and application thereof | 江苏奥首材料科技有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-117757578-A | Semiconductor chip cleaning solution containing amino acid, preparation method and application thereof | 江苏奥首材料科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-116162926-A | Copper surface antioxidant composition and preparation method thereof | 深圳市正天伟科技有限公司 | 2023-05-26 | — | — | CN | claimed |
| WO-2008077194-A1 | RECEPTOR AGONISTS | XENOME LTD (AU) | 2008-07-03 | — | — | WO | claimed |
| EP-0979827-A1 | Peptides having tachykinin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same | Boehringer Ingelheim Pharma KG (DE) | 2000-02-16 | — | — | EP | claimed |
| EP-0610487-B1 | NEW AMINOACID DERIVATES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | BOEHRINGER INGELHEIM PHARMA (DE) | 1999-11-10 | — | — | EP | claimed |
| JP-2801087-B2 | — | — | 1998-09-21 | — | — | JP | claimed |
| US-5712397-A | NEUROKININ ANTAGONISTS | BOEHRINGER INGELHEIM GMBH (DE) | 1998-01-27 | — | — | US | claimed |
| EP-0676410-B1 | Bile acids derivatives useful in the therapy of the biliary calculosis from cholesterol and of the pathologies caused by cholestasis | ALFA WASSERMANN SPA (IT) | 1997-12-03 | — | — | EP | claimed |
| EP-0804463-A1 | NEUROKININE (TACHYKININE) ANTAGONISTS | BOEHRINGER INGELHEIM KG (DE) | 1997-11-05 | — | — | EP | claimed |
| EP-0802922-A1 | NOVEL AMINO ACID DERIVATIVES, METHOD OF PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | BOEHRINGER INGELHEIM KG (DE) | 1997-10-29 | — | — | EP | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| US-5596000-A | NEUROKININ ANTAGONISTS | BOEHRINGER INGELHEIM KG (DE) | 1997-01-21 | — | — | US | claimed |
| WO-1995030687-A1 | NEUROKININE (TACHYKININE) ANTAGONISTS | BOEHRINGER INGELHEIM KG (DE) | 1995-11-16 | — | — | WO | claimed |
| WO-1995023810-A1 | NOVEL AMINO ACID DERIVATIVES, METHOD OF PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | BOEHRINGER INGELHEIM KG (DE) | 1995-09-08 | — | — | WO | claimed |
| EP-0610487-A1 | NEW AMINOACID DERIVATES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | BOEHRINGER INGELHEIM KG (DE) | 1994-08-17 | — | — | EP | claimed |
| WO-1994005693-A1 | NEW AMINOACID DERIVATES, PROCESS FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | BOEHRINGER INGELHEIM KG (DE) | 1994-03-17 | — | — | WO | claimed |
| US-12565517-B2 | Cyclic peptide having CTLA-4 inhibitory activity and use thereof | GENEFRONTIER CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| EP-0482539-A2 | Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-04-29 | — | — | EP | disclosed |
| EP-0394989-A2 | Peptide compounds, process for preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1990-10-31 | — | — | EP | disclosed |